COREMEDICO ApS: Financial statements 2023
CVR: 30070534
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
COREMEDICO ApS (CVR 30070534) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 540,649 and a net result of DKK -319,899 compared with DKK -62,624 the year before. Equity in the 2023 report amounted to DKK 6,591. The solvency ratio was 0.3%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 540,649
- Profit/Loss
- DKK -319,899
- Equity
- DKK 6,591
- Total Assets
- DKK 1,929,690
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 541 t. | -320 t. | 7 t. | 1 |
| 2022 | - | -10 t. | -63 t. | 326 t. | 0 |
| 2021 | - | -20 t. | -171 t. | 389 t. | 0 |
| 2020 | - | 31 t. | -15 t. | 560 t. | 0 |
| 2019 | - | 76 t. | 1 t. | 576 t. | 0 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
COREMEDICO ApS has published its annual report for 2022. Gross profit came to DKK -10,063, and the net result was DKK -62,624.
About COREMEDICO ApS
COREMEDICO ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2006. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Kevin Hagemann Petersen. The company is owned by JOSARDI ApS. The company has 1 employee (2016). In 2025, the company reported a gross profit of DKK -71,962 and a net result of DKK -781,873 compared with DKK -774,332 the year before. Equity in the 2025 report amounted to DKK 1,278,734.